Narjes Nasiri‐Ansari

1.4k total citations · 2 hit papers
36 papers, 1.0k citations indexed

About

Narjes Nasiri‐Ansari is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Narjes Nasiri‐Ansari has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Epidemiology and 7 papers in Endocrine and Autonomic Systems. Recurrent topics in Narjes Nasiri‐Ansari's work include Liver Disease Diagnosis and Treatment (7 papers), Circadian rhythm and melatonin (6 papers) and Diet, Metabolism, and Disease (5 papers). Narjes Nasiri‐Ansari is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Circadian rhythm and melatonin (6 papers) and Diet, Metabolism, and Disease (5 papers). Narjes Nasiri‐Ansari collaborates with scholars based in Greece, United Kingdom and United States. Narjes Nasiri‐Ansari's co-authors include Eva Kassi, Harpal Randeva, Gregory Kaltsas, Ioannis Kyrou, Athanasios G. Papavassiliou, Christina‐Maria Flessa, Θεόδωρος Ανδρουτσάκος, Antonios Chatzigeorgiou, Georgios Kyriakopoulos and Georgios K. Dimitriadis and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Cellular and Molecular Life Sciences.

In The Last Decade

Narjes Nasiri‐Ansari

35 papers receiving 995 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis

2021 234 citations Narjes Nasiri‐Ansari, Ioannis Kyrou et al. International Journal of Molecular Sciences profile →
SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection

2022 108 citations Θεόδωρος Ανδρουτσάκος, Narjes Nasiri‐Ansari et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Narjes Nasiri‐Ansari Greece	14	456	415	303	230	129	36	1.0k
Teruo Jojima Japan	18	539 1.2×	756 1.8×	355 1.2×	412 1.8×	167 1.3×	47	1.3k
Stefania Di Mauro Italy	18	215 0.5×	203 0.5×	389 1.3×	177 0.8×	122 0.9×	48	1.1k
Nobuhiko Wada Japan	13	302 0.7×	207 0.5×	210 0.7×	119 0.5×	204 1.6×	26	671
Blas A. Guigni United States	16	551 1.2×	335 0.8×	539 1.8×	233 1.0×	453 3.5×	19	1.3k
Shiying Liu China	13	586 1.3×	371 0.9×	197 0.7×	292 1.3×	187 1.4×	41	1.1k
George G. Schweitzer United States	19	577 1.3×	377 0.9×	624 2.1×	278 1.2×	567 4.4×	33	1.4k
Sara A. Beddow United States	9	779 1.7×	523 1.3×	768 2.5×	411 1.8×	445 3.4×	13	1.7k
Jinhang Zhang China	16	323 0.7×	108 0.3×	294 1.0×	160 0.7×	163 1.3×	41	926
Ming Hao China	15	300 0.7×	338 0.8×	321 1.1×	130 0.6×	58 0.4×	42	812
Laia Vilà Spain	13	465 1.0×	364 0.9×	267 0.9×	131 0.6×	402 3.1×	20	922

Countries citing papers authored by Narjes Nasiri‐Ansari

Since Specialization

Citations

This map shows the geographic impact of Narjes Nasiri‐Ansari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narjes Nasiri‐Ansari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narjes Nasiri‐Ansari more than expected).

Fields of papers citing papers by Narjes Nasiri‐Ansari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narjes Nasiri‐Ansari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narjes Nasiri‐Ansari. The network helps show where Narjes Nasiri‐Ansari may publish in the future.

Co-authorship network of co-authors of Narjes Nasiri‐Ansari

This figure shows the co-authorship network connecting the top 25 collaborators of Narjes Nasiri‐Ansari. A scholar is included among the top collaborators of Narjes Nasiri‐Ansari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narjes Nasiri‐Ansari. Narjes Nasiri‐Ansari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsave, O., Antonios G. Hatzidimitriou, Maria P. Yavropoulou, et al.. (2023). Structural Speciation of Ti(IV)-(α-Hydroxycarboxylic Acid) Complexes in Metabolism-Related (Patho)Physiology—In Vitro Approaches to (Pre)Adipocyte Differentiation and Mineralization. International Journal of Molecular Sciences. 24(14). 11865–11865. 3 indexed citations

Nasiri‐Ansari, Narjes, et al.. (2023). The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review. European Journal of Clinical Pharmacology. 80(1). 127–150. 18 indexed citations

Nasiri‐Ansari, Narjes, Georgios Zografos, Chrysanthi Aggeli, et al.. (2023). What is the role of CHCHD2 in adrenal tumourigenesis?. Endocrine. 81(2). 357–367. 2 indexed citations

Flessa, Christina‐Maria, Narjes Nasiri‐Ansari, Ioannis Kyrou, et al.. (2022). Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research. International Journal of Molecular Sciences. 23(24). 15791–15791. 64 indexed citations

Nasiri‐Ansari, Narjes, Eliana Spilioti, Ioannis Kyrou, et al.. (2022). Estrogen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Atherosclerotic Plaque Vulnerability. International Journal of Molecular Sciences. 23(18). 10960–10960. 8 indexed citations

Zoi, Ilianna, Antonios N. Gargalionis, Kostas A. Papavassiliou, et al.. (2022). Polycystin‐1 and hydrostatic pressure are implicated in glioblastoma pathogenesis in vitro. Journal of Cellular and Molecular Medicine. 26(5). 1699–1709. 8 indexed citations

Tsilingiris, Dimitrios, Narjes Nasiri‐Ansari, Nikolaos Spyrou, Faidon Magkos, & Μaria Dalamaga. (2022). Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges. Cancers. 14(10). 2494–2494. 5 indexed citations

Zografos, George, Eva Kassi, Georgios Kyriakopoulos, et al.. (2021). Adrenocortical Cancer: A 20-Year Experience of a Single Referral Center in Prognosis and Outcomes. Hormone and Metabolic Research. 53(11). 709–716. 2 indexed citations

Nasiri‐Ansari, Narjes, Ioannis Kyrou, Christos S. Mantzoros, et al.. (2021). Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis. International Journal of Molecular Sciences. 22(2). 818–818. 234 indexed citations breakdown →

10.

Evangelopoulos, Maria‐Eleftheria, Narjes Nasiri‐Ansari, Eva Kassi, et al.. (2021). Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response. Scientific Reports. 11(1). 19462–19462. 5 indexed citations

11.

Yavropoulou, Maria P., Narjes Nasiri‐Ansari, Polyzois Makras, et al.. (2020). Extra-skeletal effects of bisphosphonates. Metabolism. 110. 154264–154264. 23 indexed citations

12.

Nasiri‐Ansari, Narjes, et al.. (2020). Investigating correlation between self-reported clinical manifestation and synovial fluid and blood levels of Dickkopf-1 and sclerostin in patients with primary knee osteoarthritis. Clinical Rheumatology. 39(12). 3889–3891.

13.

Angelousi, Anna, Narjes Nasiri‐Ansari, Georgios Kyriakopoulos, et al.. (2020). Expression of clock-related genes in benign and malignant adrenal tumors. Endocrine. 68(3). 650–659. 12 indexed citations

14.

Nasiri‐Ansari, Narjes, Georgios K. Dimitriadis, Gerasimos Siasos, et al.. (2019). Orexin-A Exerts Equivocal Role in Atherosclerosis Process Depending on the Duration of Exposure: In Vitro Study. Nutrients. 12(1). 53–53. 3 indexed citations

15.

Dimitriadis, Georgios K., Narjes Nasiri‐Ansari, Georgios Agrogiannis, et al.. (2019). Empagliflozin improves primary haemodynamic parameters and attenuates the development of atherosclerosis in high fat diet fed APOE knockout mice. Molecular and Cellular Endocrinology. 494. 110487–110487. 43 indexed citations

16.

Nasiri‐Ansari, Narjes, Georgios K. Dimitriadis, Georgios Agrogiannis, et al.. (2018). Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice. Cardiovascular Diabetology. 17(1). 106–106. 125 indexed citations

17.

Nikolaou, Vasileios S., et al.. (2017). Association between serum and synovial fluid Dickkopf-1 levels with radiographic severity in primary knee osteoarthritis patients. Clinical Rheumatology. 36(8). 1865–1872. 16 indexed citations

18.

Angelousi, Anna, Nikolaos Settas, Fábio R. Faucz, et al.. (2017). Medullary thyroid cancer, leukemia, mesothelioma and meningioma associated with germline APC and RASAL1 variants: a new syndrome?. HORMONES. 16(4). 423–428. 4 indexed citations

19.

Angelousi, Anna, Narjes Nasiri‐Ansari, Eliana Spilioti, et al.. (2017). Altered expression of circadian clock genes in polyglandular autoimmune syndrome type III. Endocrine. 59(1). 109–119. 8 indexed citations

20.

Kassi, Eva, Eliana Spilioti, Narjes Nasiri‐Ansari, et al.. (2015). Vascular Inflammation and Atherosclerosis: The Role of Estrogen Receptors. Current Medicinal Chemistry. 22(22). 2651–2665. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact